464 related articles for article (PubMed ID: 7678774)
1. Selective increase in type II estrogen-binding sites in the dysplastic dorsolateral prostates of noble rats.
Ho SM; Yu M
Cancer Res; 1993 Feb; 53(3):528-32. PubMed ID: 7678774
[TBL] [Abstract][Full Text] [Related]
2. Induction of atypical hyperplasia, apoptosis, and type II estrogen-binding sites in the ventral prostates of Noble rats treated with testosterone and pharmacologic doses of estradiol-17 beta.
Ho SM; Leav I; Merk FB; Yu M; Kwan PW; Ziar J
Lab Invest; 1995 Sep; 73(3):356-65. PubMed ID: 7564268
[TBL] [Abstract][Full Text] [Related]
3. Early alterations in ras protooncogene mRNA expression in testosterone and estradiol-17 beta induced prostatic dysplasia of noble rats.
Yu M; Leav BA; Leav I; Merk FB; Wolfe HJ; Ho SM
Lab Invest; 1993 Jan; 68(1):33-44. PubMed ID: 8423674
[TBL] [Abstract][Full Text] [Related]
4. Expression and regulation of metallothionein mRNA levels in the prostates of noble rats: lack of expression in the ventral prostate and regulation by sex hormones in the dorsolateral prostate.
Ghatak S; Oliveria P; Kaplan P; Ho SM
Prostate; 1996 Aug; 29(2):91-100. PubMed ID: 8700805
[TBL] [Abstract][Full Text] [Related]
5. Hormonal regulation of nuclear type II estrogen binding sites in the dorsolateral prostate of noble rats.
Ho SM; Yu M
J Steroid Biochem Mol Biol; 1995 Mar; 52(3):233-8. PubMed ID: 7696144
[TBL] [Abstract][Full Text] [Related]
6. Effects of testosterone, and testosterone plus estrogen, in the castrated rat ventral prostate--histopathological and immunocytochemical studies.
Murakoshi M; Tagawa M; Inada R; Suzuki M
Tokai J Exp Clin Med; 1992 Oct; 17(3-4):133-7. PubMed ID: 1284451
[TBL] [Abstract][Full Text] [Related]
7. Biochemical alterations in sex hormone-induced hyperplasia and dysplasia of the dorsolateral prostates of Noble rats.
Leav I; Ho SM; Ofner P; Merk FB; Kwan PW; Damassa D
J Natl Cancer Inst; 1988 Sep; 80(13):1045-53. PubMed ID: 2457709
[TBL] [Abstract][Full Text] [Related]
8. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
Trachtenberg J; Hicks LL; Walsh PC
J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of diethylstilbestrol and estradiol-17 beta in combination with testosterone on rat prostate lobes.
Ofner P; Bosland MC; Vena RL
Toxicol Appl Pharmacol; 1992 Feb; 112(2):300-9. PubMed ID: 1539166
[TBL] [Abstract][Full Text] [Related]
10. Testosterone-mediated increase in 5 alpha-dihydrotestosterone content, nuclear androgen receptor levels, and cell division in an androgen-independent prostate carcinoma of Noble rats.
Ho SM; Leav I; Damassa D; Kwan PW; Merk FB; Seto HS
Cancer Res; 1988 Feb; 48(3):609-14. PubMed ID: 3257169
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of [3H]estradiol binding sites in the rat prostate: properties and distribution of type I and type II sites.
Yu M; Cates J; Leav I; Ho SM
J Steroid Biochem; 1989 Sep; 33(3):449-57. PubMed ID: 2779236
[TBL] [Abstract][Full Text] [Related]
12. Suppression of testosterone and estradiol-17beta-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine.
Lane KE; Leav I; Ziar J; Bridges RS; Rand WM; Ho SM
Carcinogenesis; 1997 Aug; 18(8):1505-10. PubMed ID: 9276623
[TBL] [Abstract][Full Text] [Related]
13. Sex hormone-induced alterations in the activities of antioxidant enzymes and lipid peroxidation status in the prostate of Noble rats.
Tam NN; Ghatak S; Ho SM
Prostate; 2003 Apr; 55(1):1-8. PubMed ID: 12640655
[TBL] [Abstract][Full Text] [Related]
14. Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats.
Leav I; Merk FB; Kwan PW; Ho SM
Prostate; 1989; 15(1):23-40. PubMed ID: 2477830
[TBL] [Abstract][Full Text] [Related]
15. Oral exposure to low-dose bisphenol A aggravates testosterone-induced benign hyperplasia prostate in rats.
Wu JH; Jiang XR; Liu GM; Liu XY; He GL; Sun ZY
Toxicol Ind Health; 2011 Oct; 27(9):810-9. PubMed ID: 21415097
[TBL] [Abstract][Full Text] [Related]
16. Immunolocalization of glutathione-peroxidase and androgen receptors in the rat dorsolateral prostate.
Murakoshi M; Tagawa M; Inada R; Mizokami A; Suzuki M; Watanabe K
Tokai J Exp Clin Med; 1993 Dec; 18(3-6):87-94. PubMed ID: 7701534
[TBL] [Abstract][Full Text] [Related]
17. Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
Bernoulli J; Yatkin E; Laakso A; Anttinen M; Bosland M; Vega K; Kallajoki M; Santti R; Pylkkänen L
Prostate; 2008 May; 68(7):728-39. PubMed ID: 18302197
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinases in the pathogenesis of estradiol-induced nonbacterial prostatitis in the lateral prostate lobe of the Wistar rat.
Wilson MJ; Woodson M; Wiehr C; Reddy A; Sinha AA
Exp Mol Pathol; 2004 Aug; 77(1):7-17. PubMed ID: 15215045
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase and mitogen-activated kinase phosphatase-1 expression in the Noble rat model of sex hormone-induced prostatic dysplasia and carcinoma.
Leav I; Galluzzi CM; Ziar J; Stork PJ; Ho SM; Loda M
Lab Invest; 1996 Sep; 75(3):361-70. PubMed ID: 8804359
[TBL] [Abstract][Full Text] [Related]
20. The prostate growth stimulation by progesterone is due to androgenic products and progesterone receptor-mediated mechanisms.
Nishino T; Ishibashi K; Hirtreiter C; Nishino Y
Pharmazie; 2009 Sep; 64(9):587-9. PubMed ID: 19827300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
